Forte Biosciences Stock Profit Margin
FBRX Stock | USD 7.21 0.47 6.12% |
Forte Biosciences fundamentals help investors to digest information that contributes to Forte Biosciences' financial success or failures. It also enables traders to predict the movement of Forte Stock. The fundamental analysis module provides a way to measure Forte Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Forte Biosciences stock.
Last Reported | Projected for Next Year | ||
Net Loss | (2.44) | (2.57) |
Forte | Profit Margin |
Forte Biosciences Company Profit Margin Analysis
Forte Biosciences' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Forte Biosciences Profit Margin | -2.57 |
Most of Forte Biosciences' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Forte Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Forte Profit Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for Forte Biosciences is extremely important. It helps to project a fair market value of Forte Stock properly, considering its historical fundamentals such as Profit Margin. Since Forte Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Forte Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Forte Biosciences' interrelated accounts and indicators.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition |
Forte Pretax Profit Margin
Pretax Profit Margin |
|
Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
All Next | Launch Module |
Forte Biosciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Forte Biosciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Forte Biosciences' managers, analysts, and investors.Environmental | Governance | Social |
Forte Fundamentals
Return On Equity | -1.37 | ||||
Return On Asset | -0.68 | ||||
Current Valuation | 29.73 M | ||||
Shares Outstanding | 6.39 M | ||||
Shares Owned By Insiders | 9.71 % | ||||
Shares Owned By Institutions | 80.72 % | ||||
Number Of Shares Shorted | 28.28 K | ||||
Price To Book | 5.22 X | ||||
EBITDA | (32.48 M) | ||||
Net Income | (31.48 M) | ||||
Cash And Equivalents | 38.55 M | ||||
Cash Per Share | 1.89 X | ||||
Total Debt | 3.67 M | ||||
Current Ratio | 25.67 X | ||||
Book Value Per Share | 6.42 X | ||||
Cash Flow From Operations | (28.71 M) | ||||
Short Ratio | 0.74 X | ||||
Earnings Per Share | (15.44) X | ||||
Target Price | 107.0 | ||||
Number Of Employees | 11 | ||||
Beta | 2.88 | ||||
Market Capitalization | 46.1 M | ||||
Total Asset | 38.98 M | ||||
Retained Earnings | (118.52 M) | ||||
Working Capital | 34.66 M | ||||
Net Asset | 38.98 M |
About Forte Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Forte Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Forte Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Forte Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Forte Stock Analysis
When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.